[A Case of Initially Locally Advanced Pancreatic Cancer Curatively Resected after Carbon-Ion Radiotherapy with Gemcitabine]

Gan To Kagaku Ryoho. 2020 Dec;47(13):2266-2268.
[Article in Japanese]

Abstract

Background: The neoadjuvant therapy against locally advanced pancreatic cancer(LAPC)have been developed by combining radiation with chemotherapy. We experienced a case of LAPC performed R0 resection and obtained high histopathological effect by carbon-ion radiotherapy with gemcitabine(GEM).

Case presentation: A 65-year-old male with epigastric and back pain was suspected as pancreas cancer by FDG-PET/CT scan, and was referred to our hospital. CT scan revealed a tumor in pancreatic body with poor contrast effect and with invasion to celiac artery, common hepatic artery and portal vein, and diagnosed as pancreatic adenocarcinoma by endoscopic ultrasound-fine needle aspiration(EUS-FNA). Therefore we diagnosed the tumor as pancreatic body cancer, cT4, cN1a, cM0, cStage Ⅲ, UR-LA. GEM plus nab-paclitaxel(GnP)were administered for 4 months followed by carbon-ion radiotherapy with GEM at other hospital. Distal pancreatectomy with en bloc celiac axis resection(DP-CAR)was performed 3 months after irradiation. High therapeutic effect was obtained histopathologically( Evans grade Ⅲ), and lesions outside the pancreas disappeared except for metastasis to one lymph node (ypT1c, ypN1a, ycM0, ypStage ⅡB), and R0 resection was performed.

Conclusion: Carbon-ion radiotherapy with chemotherapy for LAPC may improve curative resection rate.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / surgery
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carbon / therapeutic use
  • Deoxycytidine / analogs & derivatives
  • Gemcitabine
  • Humans
  • Male
  • Neoadjuvant Therapy
  • Pancreas
  • Pancreatectomy
  • Pancreatic Neoplasms* / surgery
  • Positron Emission Tomography Computed Tomography

Substances

  • Deoxycytidine
  • Carbon
  • Gemcitabine